As part of its new Women’s Wellness initiative, Schnuck Markets is offering four oral breast cancer medications for $9 with a prescription.
The four medications — Letrozole 2.5mg/30-count; Megestrol 40mg/60-count; Anastrozole, 1mg/30-count; Tamoxifen 10mg/60-count; and Tamoxifen 20mg/30-count — are breast-cancer specific (although sometimes used on other cancers) and approved by most insurance plans, according to Schnuck.
Schnuck is the first pharmacy to target the breast cancer category for discount, said Mike Juergensmeyer, Schnuck Market’s VP of pharmacy.
“Offering significant discounts on four highly-prescribed prescription drugs, allows us to make an even greater difference in the lives of women battling breast cancer,” he said in a statement.
Helen Chesnut, executive director of Susan G. Komen St. Louis, commended on the initiative.
“We appreciate Schnucks’ commitment to women’s health,” Chesnut said in a statement.
Schnuck has partnered with Komen St. Louis for more than 15 years to help raise awareness and funds for breast cancer research and local breast health programs.
Schnuck also offers free generic oral antibiotics, free prescription prenatal vitamins, $2 oral diabetes medications, and $4 30-day and $10 90-day generic prescriptions.
| Suggested Categories | More from Supermarketnews |
 |
|
|
|
